KCM
BHVN icon

Kynam Capital Management’s Biohaven BHVN Stock Holding History

Kynam Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-702,884
Closed -$5.95M – 34
2026
Q1 		$5.95M Hold
702,884
– – 0.37% 33
2025
Q4 		$7.94M Buy
+702,884
New +$8.71M 0.51% 26

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kynam Capital Management's BHVN Position: Q2 2026 in Review

Kynam Capital Management sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 702,884 shares — an estimated $5.95M sold.

Kynam Capital Management first reported a position in BHVN in Q4 2025 and held it in 2 quarters. The position peaked at $7.94M in Q4 2025. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Kynam Capital Management reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Kynam Capital Management sold 702,884 Biohaven shares in Q2 2026, an estimated $5.95M.
  • Kynam Capital Management first reported a position in Biohaven in Q4 2025 and held it in 2 quarters.
  • Kynam Capital Management's Biohaven position peaked at $7.94M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Kynam Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.